METHOD AND COMPOSITION FOR INHIBITING VIRUS INFECTION

The present invention pertains to a compound, particularly ovatodiolide, for use in preventing or treating an infection of a virus, including a hepatitis virus, an influenza virus, a herpes simplex virus, an enterovirus, a rotavirus, a dengue virus, a poxvirus, a human immunodeficiency virus, an ade...

Full description

Saved in:
Bibliographic Details
Main Authors WU, Yeh B, HUANG, Cheng, LO, Jir-Mehng, LIANG, Hui Ju
Format Patent
LanguageEnglish
French
Published 27.01.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention pertains to a compound, particularly ovatodiolide, for use in preventing or treating an infection of a virus, including a hepatitis virus, an influenza virus, a herpes simplex virus, an enterovirus, a rotavirus, a dengue virus, a poxvirus, a human immunodeficiency virus, an adenovirus, a coronavirus, an arenavirus, a measles virus, a retrovirus and a norovirus, particularly SARS-COV-2. Also provided are the method for preventing or treating a virus infection using the compound, and the pharmaceutical composition or composition comprising the compound. La présente invention concerne un composé, en particulier un ovatodiolide, destiné à être utilisé dans la prévention ou le traitement d'une infection par un virus, comprenant un virus de l'hépatite, un virus de la grippe, un virus de l'herpès simplex, un entérovirus, un rotavirus, un virus de la dengue, un poxvirus, un virus de l'immunodéficience humaine, un adénovirus, un coronavirus, un arénavirus, un virus de la rougeole, un rétrovirus et un norovirus, en particulier le SARS-COV -2. L'invention concerne également une méthode de prévention ou de traitement d'une infection virale à l'aide du composé, ainsi que la composition pharmaceutique ou composition comprenant ce composé.
Bibliography:Application Number: WO2021US42895